2011 – Danish Medicines Agency approved medical use of cannabis derivatives.
Sativex, Marinol and Nabilone are available on prescription.
Source: laegemiddelstyrelsen.dk
From 1st January, 2018 onward, medical cannabis products are available for Danish patients and are handed out from pharmacies and hospitals. This follows a parliamentary vote in December 2017 which approved a four-year trial for access to medical cannabis.
The Danish Medicines Agency has recommended four patient groups that can benefit from medical cannabis: multiple sclerosis, spinal cord injuries, chronic pain, and chemotherapy-induced nausea. However, a doctor is allowed to prescribe medical cannabis to patients with other conditions if it can be professionally justified.
Source: Healthcare Denmark
